New Delhi: Shares of Dr Reddy's Laboratories jumped nearly 10 per cent in early trade on Friday after the company said it has settled a litigation with a unit of Bristol Myers Squibb related to patents for Revlimid (lenalidomide) capsules, used in the treatment of cancer. Continuing its rally for the fourth consecutive day, the stock gained 9.86 per cent to Rs 5,302.85 -- its record high level -- on the BSE.To Contact Insurance and Investment Expert
Thanks for reading. Please Share, Comment, Like the post And Follow, Subscribe Insurance and Investment News
from Source
Dr Reddy's shares extend rally; zoom nearly 10 pc
![Dr Reddy's shares extend rally; zoom nearly 10 pc]()
Reviewed by Insurance Advisor
on
September 18, 2020
Rating:
No comments: